Insulet Corp. (PODD) PS Ratio: 3.60
Is Insulet Corp.’s P/S ratio high or low?
Insulet Corp.'s P/S ratio of 3.60 is 69% below its 5-year average of 11.79, near the low end of its 5-year range (3.36–21.36).
As of Thursday, June 25, 2026. 52.68% below its 12-month average of 7.61.
PODD PS Ratio Chart
PODD Average PS Ratio Chart
PODD Current vs Average PS Ratio Chart
PODD PS Ratio Metrics
PS RATIO
3.60
PS RATIO AVG TTM
7.61
PS RATIO AVG 3Y
8.56
PS RATIO AVG 5Y
11.79
PS RATIO AVG 10Y
11.89
PS RATIO AVG 15Y
10.20
PS RATIO AVG 20Y
9.80
CURRENT VS TTM AVG
-52.68%
CURRENT VS 3Y AVG
-57.95%
CURRENT VS 5Y AVG
-69.46%
CURRENT VS 10Y AVG
-69.73%
CURRENT VS 15Y AVG
-64.72%
CURRENT VS 20Y AVG
-63.28%
PODD Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 3.60 | 7.61 | 8.56 | 11.79 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.07 | 0.06 | 0.13 | 0.20 |
| Baxter International Inc. (BAX)vs › | $10.87B | 0.96 | 0.98 | 1.30 | 1.78 |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | 2.46 | 2.15 | 2.36 | 3.05 |
| Henry Schein, Inc. (HSIC)vs › | $9.38B | 0.69 | 0.68 | 0.72 | 0.79 |
| Revvity, Inc. (RVTY)vs › | $11.78B | 4.07 | 3.93 | 4.56 | 4.63 |
| Align Technology, Inc. (ALGN)vs › | $12.24B | 2.99 | 2.93 | 4.24 | 6.04 |
| Solventum Corporation (SOLV)vs › | $13.01B | 1.57 | 1.56 | 1.48 | 1.48 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 2.92 | 3.04 | 3.29 | 4.29 |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | 0.72 | 0.43 | 0.49 | 0.72 |
P/S vs. its own history
At 3.60, P/S is cheaper than usual, sitting higher than 2% of its 19-year history.
19-year low
1.33
median
8.56
19-year high
67.86
Sales Valuation
P/S Ratio
3.60
Market Cap / Annual Revenue
Insulet Corp. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Insulet Corp. PS Ratio FAQ
- What is the P/S ratio for Insulet Corp. (PODD)?
- The P/S ratio for PODD stock is 3.60.
- Is Insulet Corp.'s P/S ratio high or low?
- Insulet Corp.'s P/S ratio of 3.60 is 69% below its 5-year average of 11.79, near the low end of its 5-year range (3.36–21.36).
- What is the TTM average P/S ratio for Insulet Corp. (PODD)?
- The TTM average P/S ratio for PODD stock is 7.61.
- What is the 3Y average P/S ratio for Insulet Corp. (PODD)?
- The 3Y average P/S ratio for PODD stock is 8.56.
- What is the 5Y average P/S ratio for Insulet Corp. (PODD)?
- The 5Y average P/S ratio for PODD stock is 11.79.
- What is the 10Y average P/S ratio for Insulet Corp. (PODD)?
- The 10Y average P/S ratio for PODD stock is 11.89.
- What is the 15Y average P/S ratio for Insulet Corp. (PODD)?
- The 15Y average P/S ratio for PODD stock is 10.20.
- What is the 20Y average P/S ratio for Insulet Corp. (PODD)?
- The 20Y average P/S ratio for PODD stock is 9.80.
Insulet Corp. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-24 | 3.60 |
| 2026-06-23 | 3.48 |
| 2026-06-22 | 3.36 |
| 2026-06-18 | 3.53 |
| 2026-06-17 | 3.47 |
| 2026-06-16 | 3.57 |
| 2026-06-15 | 3.58 |
| 2026-06-12 | 3.62 |
| 2026-06-11 | 3.61 |
| 2026-06-10 | 3.65 |
| 2026-06-09 | 3.86 |
| 2026-06-08 | 3.67 |
| 2026-06-05 | 3.71 |
| 2026-06-04 | 3.54 |
| 2026-06-03 | 3.47 |
| 2026-06-02 | 3.45 |
| 2026-06-01 | 3.58 |
| 2026-05-29 | 3.51 |
| 2026-05-28 | 3.45 |
| 2026-05-27 | 3.53 |
| 2026-05-26 | 3.72 |
| 2026-05-22 | 3.75 |
| 2026-05-21 | 3.80 |
| 2026-05-20 | 3.79 |
| 2026-05-19 | 3.74 |
| 2026-05-18 | 3.69 |
| 2026-05-15 | 3.57 |
| 2026-05-14 | 3.60 |
| 2026-05-13 | 3.60 |
| 2026-05-12 | 3.83 |
| 2026-05-11 | 3.73 |
| 2026-05-08 | 3.73 |
| 2026-05-07 | 3.88 |
| 2026-05-06 | 3.66 |
| 2026-05-05 | 4.37 |
| 2026-05-04 | 4.47 |
| 2026-05-01 | 4.57 |
| 2026-04-30 | 4.49 |
| 2026-04-29 | 4.18 |
| 2026-04-28 | 4.77 |
| 2026-04-27 | 4.91 |
| 2026-04-24 | 4.95 |
| 2026-04-23 | 5.02 |
| 2026-04-22 | 5.05 |
| 2026-04-21 | 5.02 |
| 2026-04-20 | 5.24 |
| 2026-04-17 | 5.32 |
| 2026-04-16 | 5.26 |
| 2026-04-15 | 5.28 |
| 2026-04-14 | 5.26 |
| 2026-04-13 | 5.16 |
| 2026-04-10 | 5.14 |
| 2026-04-09 | 5.20 |
| 2026-04-08 | 5.31 |
| 2026-04-07 | 5.28 |
| 2026-04-06 | 5.31 |
| 2026-04-02 | 5.33 |
| 2026-04-01 | 5.40 |
| 2026-03-31 | 5.48 |
| 2026-03-30 | 5.43 |
| 2026-03-27 | 5.43 |
| 2026-03-26 | 5.69 |
| 2026-03-25 | 5.64 |
| 2026-03-24 | 5.88 |
| 2026-03-23 | 5.93 |
| 2026-03-20 | 5.93 |
| 2026-03-19 | 5.97 |
| 2026-03-18 | 6.01 |
| 2026-03-17 | 6.01 |
| 2026-03-16 | 5.86 |
| 2026-03-13 | 5.74 |
| 2026-03-12 | 6.16 |
| 2026-03-11 | 6.23 |
| 2026-03-10 | 6.22 |
| 2026-03-09 | 6.27 |
| 2026-03-06 | 6.18 |
| 2026-03-05 | 6.29 |
| 2026-03-04 | 6.34 |
| 2026-03-03 | 6.31 |
| 2026-03-02 | 6.40 |
| 2026-02-27 | 6.43 |
| 2026-02-26 | 6.56 |
| 2026-02-25 | 6.47 |
| 2026-02-24 | 6.40 |
| 2026-02-23 | 6.51 |
| 2026-02-20 | 6.31 |
| 2026-02-19 | 6.50 |
| 2026-02-18 | 6.73 |
| 2026-02-17 | 6.90 |
| 2026-02-13 | 6.80 |
| 2026-02-12 | 6.75 |
| 2026-02-11 | 7.03 |
| 2026-02-10 | 7.07 |
| 2026-02-09 | 6.88 |
| 2026-02-06 | 6.78 |
| 2026-02-05 | 6.81 |
| 2026-02-04 | 7.04 |
| 2026-02-03 | 7.04 |
| 2026-02-02 | 7.19 |
| 2026-01-30 | 7.17 |
| 2026-01-29 | 7.15 |
| 2026-01-28 | 7.23 |
| 2026-01-27 | 7.42 |
| 2026-01-26 | 7.60 |
| 2026-01-23 | 7.61 |
| 2026-01-22 | 7.85 |
| 2026-01-21 | 7.98 |
| 2026-01-20 | 7.96 |
| 2026-01-16 | 8.06 |
| 2026-01-15 | 8.03 |
| 2026-01-14 | 7.93 |
| 2026-01-13 | 7.79 |
| 2026-01-12 | 7.80 |
| 2026-01-09 | 8.10 |
| 2026-01-08 | 8.21 |
| 2026-01-07 | 8.38 |
| 2026-01-06 | 8.25 |
| 2026-01-05 | 7.94 |
| 2026-01-02 | 7.93 |
| 2025-12-31 | 7.96 |
| 2025-12-30 | 8.04 |
| 2025-12-29 | 8.05 |
| 2025-12-26 | 8.09 |
| 2025-12-24 | 8.09 |
| 2025-12-23 | 8.00 |
| 2025-12-22 | 8.17 |
| 2025-12-19 | 8.11 |
| 2025-12-18 | 8.21 |
| 2025-12-17 | 8.11 |
| 2025-12-16 | 8.09 |
| 2025-12-15 | 8.17 |
| 2025-12-12 | 8.29 |
| 2025-12-11 | 8.24 |
| 2025-12-10 | 8.27 |
| 2025-12-09 | 8.24 |
| 2025-12-08 | 8.30 |
| 2025-12-05 | 8.53 |
| 2025-12-04 | 8.85 |
| 2025-12-03 | 8.62 |
| 2025-12-02 | 8.66 |
| 2025-12-01 | 8.71 |
| 2025-11-28 | 9.17 |
| 2025-11-26 | 9.16 |
| 2025-11-25 | 9.21 |
| 2025-11-24 | 9.46 |
| 2025-11-21 | 9.28 |
| 2025-11-20 | 8.77 |
| 2025-11-19 | 9.70 |
| 2025-11-18 | 9.34 |
| 2025-11-17 | 9.19 |
| 2025-11-14 | 9.32 |
| 2025-11-13 | 9.32 |
| 2025-11-12 | 9.44 |
| 2025-11-11 | 9.14 |
| 2025-11-10 | 8.98 |
| 2025-11-07 | 8.96 |
| 2025-11-06 | 9.06 |
| 2025-11-05 | 9.41 |
| 2025-11-04 | 9.59 |
| 2025-11-03 | 9.54 |
| 2025-10-31 | 9.37 |
| 2025-10-30 | 9.34 |
| 2025-10-29 | 9.47 |
| 2025-10-28 | 9.71 |
| 2025-10-27 | 9.75 |
| 2025-10-24 | 9.61 |
| 2025-10-23 | 9.68 |
| 2025-10-22 | 9.86 |
| 2025-10-21 | 9.85 |
| 2025-10-20 | 9.79 |
| 2025-10-17 | 9.54 |
| 2025-10-16 | 9.47 |
| 2025-10-15 | 9.35 |
| 2025-10-14 | 9.53 |
| 2025-10-13 | 9.42 |
| 2025-10-10 | 9.42 |
| 2025-10-09 | 9.59 |
| 2025-10-08 | 9.45 |
| 2025-10-07 | 9.38 |
| 2025-10-06 | 9.33 |
| 2025-10-03 | 9.25 |
| 2025-10-02 | 9.35 |
| 2025-10-01 | 9.16 |
| 2025-09-30 | 9.24 |
| 2025-09-29 | 9.30 |
| 2025-09-26 | 9.52 |
| 2025-09-25 | 9.69 |
| 2025-09-24 | 9.79 |
| 2025-09-23 | 9.81 |
| 2025-09-22 | 10.03 |
| 2025-09-19 | 9.91 |
| 2025-09-18 | 9.98 |
| 2025-09-17 | 9.65 |
| 2025-09-16 | 9.94 |
| 2025-09-15 | 10.19 |
| 2025-09-12 | 10.23 |
| 2025-09-11 | 10.12 |
| 2025-09-10 | 10.11 |
| 2025-09-09 | 10.56 |
| 2025-09-08 | 10.47 |
| 2025-09-05 | 10.43 |
| 2025-09-04 | 10.37 |
| 2025-09-03 | 10.28 |
| 2025-09-02 | 10.33 |
| 2025-08-29 | 10.18 |
| 2025-08-28 | 10.11 |
| 2025-08-27 | 10.01 |
| 2025-08-26 | 9.93 |
| 2025-08-25 | 9.85 |
| 2025-08-22 | 9.90 |
| 2025-08-21 | 9.82 |
| 2025-08-20 | 9.97 |
| 2025-08-19 | 9.80 |
| 2025-08-18 | 9.67 |
| 2025-08-15 | 9.62 |
| 2025-08-14 | 9.45 |
| 2025-08-13 | 9.24 |
| 2025-08-12 | 9.27 |
| 2025-08-11 | 9.13 |
| 2025-08-08 | 9.19 |
| 2025-08-07 | 9.09 |
| 2025-08-06 | 9.35 |
| 2025-08-05 | 9.47 |
| 2025-08-04 | 9.70 |
| 2025-08-01 | 9.60 |
| 2025-07-31 | 9.72 |
| 2025-07-30 | 10.05 |
| 2025-07-29 | 9.82 |
| 2025-07-28 | 9.85 |
| 2025-07-25 | 9.78 |
| 2025-07-24 | 9.66 |
| 2025-07-23 | 9.66 |
| 2025-07-22 | 9.62 |
| 2025-07-21 | 9.47 |
| 2025-07-18 | 9.58 |
| 2025-07-17 | 9.55 |
| 2025-07-16 | 9.72 |
| 2025-07-15 | 9.77 |
| 2025-07-14 | 9.84 |
| 2025-07-11 | 9.75 |
| 2025-07-10 | 10.02 |
| 2025-07-09 | 10.03 |
| 2025-07-08 | 9.99 |
| 2025-07-07 | 10.13 |
| 2025-07-03 | 10.15 |
| 2025-07-02 | 10.17 |
| 2025-07-01 | 10.11 |
| 2025-06-30 | 10.59 |
| 2025-06-27 | 10.55 |
| 2025-06-26 | 10.44 |
| 2025-06-25 | 10.32 |
| 2025-06-24 | 10.48 |
| 2025-06-23 | 10.37 |
| 2025-06-20 | 10.22 |
| 2025-06-18 | 10.17 |
| 2025-06-17 | 10.26 |
| 2025-06-16 | 10.33 |
| 2025-06-13 | 10.27 |
| 2025-06-12 | 10.23 |
| 2025-06-11 | 10.19 |
Showing the most recent 260 of 4,808 data points. The chart above shows the full history.
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy